We also have a range of existing and emerging treatments for use in hospital to treat the symptoms of infection – inflammation on the lungs and difficulty breathing.
If patients with mild COVID have certain risk factors for disease progression, such as diabetes or a heart condition, doctors may consider using hospital administered treatments such as sotrovimab, Ronapreve, or inhaled budesonide to prevent disease progression. According to Pfizer's trial results, Paxlovid could be used as an alternative to in-hospital treatment for preventing disease progression in patients with the same risk factors.WatchThere are several steps before we can routinely expect to take COVID drugs at home to prevent the worst of the symptoms. We need independent verification of these drugs' efficacy and safety, and of course, regulatory approval.
The daily cost of a patient in hospital is around $5,000 for an uncomplicated admission. This is much more than the reported cost of a full course of molnupiravir to the US government at US$700 . But the costs of Paxlovid, and other new COVID medicines, have not been released and may be very much higher than the hospital costs. Some medicines subsidised by the government for other conditions can cost almost $19,000 per pack of tablets.Elise Schubert is a pharmacist and PhD candidate at the University of Sydney. This piece first appeared on
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: smh - 🏆 6. / 80 Read more »
COVID-19 booster shots 'not optional' for people with breast cancerPeople with breast cancer are being urged to get a COVID-19 booster shot as soon as possible, with those undergoing breast cancer treatment eligible for the dose much earlier than others. We have reached the point where the government is now forcing the sick to get injected with an unknown drug Ohhhhhhh my god
Source: 9NewsAUS - 🏆 10. / 72 Read more »